Amid the global outbreak of Mpox, the World Health Organization (WHO) on Thursday announced prequalifying Bavarian Nordic’s ...

The MVA-BN vaccine, designed for smallpox, has shown 58% effectiveness against mpox after a single dose in a Canadian study.

The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved for active immunization against smallpox, Mpox, and ...

The WHO has added the MVA-BN vaccine by Bavarian Nordic A/S to its list of prequalified vaccines against monkeypox, aiming to enhance access in high-need regions. The vaccine is effective at 76% ...

Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...

On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its ...

At the start of the monkeypox outbreak ... scrambling for a limited pool of vaccines and treatments with unclear effectiveness. Under the deal, Bavarian Nordic could receive as much as $975 ...

The World Health Organization (WHO) on Friday said it has granted its first authorisation for the use of a vaccine against Mpox in adults, marking a crucial advancement in combating the disease in ...

The Vaccine Alliance, Gavi, and Bavarian Nordic announced an Advance Purchase ... mpox vaccine for countries in Africa affected by the monkeypox outbreak. According to a press statement issued ...

The global vaccine alliance Gavi will buy 500,000 doses of mpox vaccine to battle outbreaks of the disease in African ...

The WHO has prequalified Bavarian Nordic's Jynneos mpox vaccine, enabling UN agencies to purchase it for Africa's outbreak control.

As mpox continues to cause illness and claim lives in Africa, Bavarian Nordic is retooling certain vaccine supply pacts to ensure its vaccine goes to the regions that need it most. < | Facing high ...